CN112451407A - 一种以光甘草定为主具有高效美白的精华液及其制备方法 - Google Patents
一种以光甘草定为主具有高效美白的精华液及其制备方法 Download PDFInfo
- Publication number
- CN112451407A CN112451407A CN202011505225.4A CN202011505225A CN112451407A CN 112451407 A CN112451407 A CN 112451407A CN 202011505225 A CN202011505225 A CN 202011505225A CN 112451407 A CN112451407 A CN 112451407A
- Authority
- CN
- China
- Prior art keywords
- extract
- essence
- glabridin
- mixed solution
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 title claims abstract description 37
- 229940093767 glabridin Drugs 0.000 title claims abstract description 37
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 title claims abstract description 37
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 230000002087 whitening effect Effects 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 95
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 23
- 239000002738 chelating agent Substances 0.000 claims abstract description 23
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 23
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 23
- 239000002562 thickening agent Substances 0.000 claims abstract description 23
- 239000003906 humectant Substances 0.000 claims abstract description 21
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 15
- 229940069765 bean extract Drugs 0.000 claims abstract description 15
- 235000021279 black bean Nutrition 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 240000001548 Camellia japonica Species 0.000 claims abstract description 13
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 13
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 13
- 240000000147 Torreya grandis Species 0.000 claims abstract description 13
- 235000016410 Torreya grandis Nutrition 0.000 claims abstract description 13
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 13
- 235000018597 common camellia Nutrition 0.000 claims abstract description 13
- 230000037303 wrinkles Effects 0.000 claims abstract description 13
- 239000009141 Houttuynia cordata plant extract Substances 0.000 claims abstract description 12
- 240000000249 Morus alba Species 0.000 claims abstract description 9
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims abstract description 6
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 5
- 239000011259 mixed solution Substances 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 25
- 235000006490 Nymphaea odorata Nutrition 0.000 claims description 12
- 240000006908 Nymphaea odorata Species 0.000 claims description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 10
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 10
- 239000002585 base Substances 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 10
- 241000167854 Bourreria succulenta Species 0.000 claims description 9
- 235000019693 cherries Nutrition 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 5
- 241001530056 Athelia rolfsii Species 0.000 claims description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical group [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 5
- 229920002125 Sokalan® Polymers 0.000 claims description 5
- 229920000392 Zymosan Polymers 0.000 claims description 5
- 229960001631 carbomer Drugs 0.000 claims description 5
- 229920006037 cross link polymer Polymers 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229960003966 nicotinamide Drugs 0.000 claims description 5
- 235000005152 nicotinamide Nutrition 0.000 claims description 5
- 239000011570 nicotinamide Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical group OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 5
- 229960000281 trometamol Drugs 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 239000002075 main ingredient Substances 0.000 claims 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 8
- 244000141698 Prunus lannesiana Species 0.000 abstract description 4
- 235000014001 Prunus serrulata Nutrition 0.000 abstract description 4
- 239000000419 plant extract Substances 0.000 abstract description 3
- 230000001256 tonic effect Effects 0.000 abstract description 3
- 241000209490 Nymphaea Species 0.000 abstract 1
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- -1 Flavonoid compounds Chemical class 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种以光甘草定为主具有高效美白的精华液,原料包括:光甘草定,烟酰胺,樱花花提取物,山茶花提取物,香榧籽提取物,白睡莲提取物,鱼腥草提取物,红景天提取物,黑豆提取物,桑白皮提取物,苦参提取物,增稠剂,瞬间祛皱剂,水解透明质酸钠,透明质酸钠,保湿剂,螯合剂,酸碱调节剂,香精,水补充至。本发明的精华液含有多种植物提取物,制备工艺简单方便,易于控制,生产出的精华液很稳定,且易吸收、保湿、美白效果好,使用此款发明,可以有效阻碍黑色素的产生,不光起到日常护肤补品的作用,还可以防护肌肤,值得注意的是,精华液是最高浓度的保养品,用量得有一定标准。
Description
技术领域
本发明涉及一种精华液及其制备方法,特别涉及一种以光甘草定为主具有高效美白的精华液及其制备方法。
背景技术
甘草中黄酮类化合物具有抗炎 、抗溃疡 、抗氧化等作用,光甘草定是光果甘草中一种特有的异黄酮成分目前国内外研究显示光甘草定在调血脂和降血压方面具有很明显的效果除此之外,它在美容行业也受到越来越多的关注。黑色素、自由基是引起人体肌肤衰老的重要因素, 酪氨酸酶(tyrosinase)是皮肤黑色素生物合成的关键酶,酪氨酸酶和清除自由基来达到美白肌肤的作用,从而市场上对于美白的需求量会更多,广泛的运用于水乳霜里,而光甘草定本身原料就很贵,因而可采用跟红景天提取物、黑豆提取物、桑白皮提取物复合,可以降低成本,进而既解决成本问题又比单一的美白效果更高,我们都知道精华液在化妆品的分类当中,一般都是指有效成份浓度较高的产品,在使用过程当中,能够因为高比例的有效成份,来加强特殊目的的护理作用,让肌肤达到比较明显的护肤效果,但是由于光甘草定本身很难溶于水,易溶于油相,本发明采用光甘草定溶液与其复合添加。市面上大多数都是一些概念性或者只有一点点美白效果,而本发明就能很好的解决市面上人们对于美白方面上面的需求。
发明内容
本发明的目的在于提供一种以光甘草定为主具有高效美白的精华液及其制备方法。
本发明采用的技术方案是:
一种以光甘草定为主具有高效美白的精华液,其特征在于:由以下重量百分比的原料制成:光甘草定0-1%、烟酰胺0.5-5%、樱花提取物0-2%、山茶花提取物0-1.5%、香榧籽提取物0-2.5%、白睡莲提取物0-2%、鱼腥草提取物0-2%、红景天提取物0.5-6%、黑豆提取物0.5-5%、桑白皮提取物0.5-3%、苦参提取物0.1-5%、增稠剂0-0.9%、瞬间祛皱剂0.1-3%、水解透明质酸钠0.001-0.1%、透明质酸钠0.005-0.5%、保湿剂0.005-1%、螯合剂0.01-0.5%、酸碱调节剂0.01-4%、香精0.001-0.1%、水补足至100%。
优选的,由以下重量百分比的原料制成:光甘草定0.02-0.5%、烟酰胺1-3%、樱花提取物0.01-0.5%、山茶花提取物0.05-0.3%、香榧籽提取物0.08-0.4%、白睡莲提取物0.08-0.3%、鱼腥草提取物0.01-0.4%、红景天提取物1-3%、黑豆提取物0.8-2%、桑白皮提取物0.6-2%、苦参提取物0.5-2%、增稠剂0.02-0.5%、瞬间祛皱剂0.1-1.5%、水解透明质酸0.005-0.1%、透明质酸钠0.005-0.1%、保湿剂0.1-0.5%、螯合剂0.01-0.05%、酸碱调节剂0.05-3%、香精0.001-0.05%、水补充至100%。
所述增稠剂为卡波姆、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物、黄原胶、小核菌胶中的至少两种。
所述保湿剂为酵母多糖,所述螯合剂为乙二胺四乙酸二钠,所述酸碱调节剂为氨丁三醇。
一种以光甘草定为主具有高效美白的精华液的制备方法,其特征在于,包括以下步骤:
步骤1:取适量水,加热至60-80℃后依次加入增稠剂、螯合剂、保湿剂、烟酰胺搅拌至完全溶解得到一次混合液;
步骤2:将一次混合液降温至55-60℃,依次加入樱花提取物、山茶花提取物、香榧籽提取物、白睡莲提取物、鱼腥草提取物、红景天提取物、黑豆提取物、桑白皮提取物、苦参提取物搅拌至完全溶解,得二次混合液;
步骤3:将二次混合液中依次加入瞬间祛皱剂、水解透明质酸钠、透明质酸钠搅拌至完全溶解,得三次混合液;
步骤4:将三次混合液降温35-40℃加入光甘草定搅拌至完全溶解,加入酸碱调节剂调节pH为5.0-7.0;
步骤5:加入香精,混合搅拌均匀后检测、包装、入库。
本发明的优点:本发明的精华液含有多种植物提取物,制备工艺简单方便,易于控制,生产出的精华液很稳定,且易吸收、保湿、美白效果好,针对干性的皮肤容易长斑的人群特别的适用,包括一些皮肤暗沉没有光泽的皮肤。使用此款发明,可以有效阻碍黑色素的产生,不光起到日常护肤补品的作用,还可以防护肌肤,值得注意的是,精华液是最高浓度的保养品,用量得有一定标准。
具体实施方式
实施例1
一种以光甘草定为主具有高效美白的精华液,由以下重量百分比的原料制成:光甘草定0.05%,烟酰胺1%,樱花花提取物0.1%,山茶花提取物0.08%,香榧籽提取物0.08%,白睡莲提取物0.1%,鱼腥草提取物0.05%,红景天提取物1%,黑豆提取物0.8%,桑白皮提取物0.6%,苦参提取物0.5%,增稠剂0.08%,瞬间祛皱剂0.1%,水解透明质酸钠0.005%,透明质酸钠0.009%,保湿剂0.1%,螯合剂0.01%,酸碱调节剂0.08%,香精0.005%,水补充至100%。
其中,增稠剂为卡波姆、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物、黄原胶、小核菌胶中的至少两种;保湿剂为酵母多糖,螯合剂为乙二胺四乙酸二钠,酸碱调节剂为氨丁三醇。
一种以光甘草定为主具有高效美白的精华液的制备方法,包括以下步骤:
步骤1:取适量水,加热至60℃后依次加入增稠剂、螯合剂、保湿剂、烟酰胺搅拌至完全溶解得到一次混合液;
步骤2:将一次混合液降温至55℃,依次加入樱花提取物、山茶花提取物、香榧籽提取物、白睡莲提取物、鱼腥草提取物、红景天提取物、黑豆提取物、桑白皮提取物、苦参提取物搅拌至完全溶解,得二次混合液;
步骤3:将二次混合液中依次加入瞬间祛皱剂、水解透明质酸钠、透明质酸钠搅拌至完全溶解,得三次混合液;
步骤4:将三次混合液降温35℃加入光甘草定搅拌至完全溶解,加入酸碱调节剂调节pH为5.0;
步骤5:加入香精,混合搅拌均匀后检测、包装、入库。
实施例2
一种以光甘草定为主具有高效美白的精华液,由以下重量百分比的原料制成:光甘草定0.08%,烟酰胺1.5%,樱花花提取物0.3%,山茶花提取物0.1%,香榧籽提取物0.1%,白睡莲提取物0.2%,鱼腥草提取物0.2%,红景天提取物1.5%,黑豆提取物1%,桑白皮提取物1%,苦参提取物0.8%,增稠剂0.1%,瞬间祛皱剂0.2%,水解透明质酸钠0.008%,透明质酸钠0.01%,保湿剂0.3%,螯合剂0.02%,酸碱调节剂0.1%,香精0.008%,水补充至100%。
增稠剂为卡波姆、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物、黄原胶、小核菌胶中的至少两种;保湿剂为酵母多糖,螯合剂为乙二胺四乙酸二钠,酸碱调节剂为氨丁三醇。
一种以光甘草定为主具有高效美白的精华液的制备方法,包括以下步骤:
步骤1:取适量水,加热至80℃后依次加入增稠剂、螯合剂、保湿剂、烟酰胺搅拌至完全溶解得到一次混合液;
步骤2:将一次混合液降温至60℃,依次加入樱花提取物、山茶花提取物、香榧籽提取物、白睡莲提取物、鱼腥草提取物、红景天提取物、黑豆提取物、桑白皮提取物、苦参提取物搅拌至完全溶解,得二次混合液;
步骤3:将二次混合液中依次加入瞬间祛皱剂、水解透明质酸钠、透明质酸钠搅拌至完全溶解,得三次混合液;
步骤4:将三次混合液降温40℃加入光甘草定搅拌至完全溶解,加入酸碱调节剂调节pH为7.0;
步骤5:加入香精,混合搅拌均匀后检测、包装、入库。
实施例3
一种以光甘草定为主具有高效美白的精华液,由以下重量百分比的原料制成:光甘草定0.5%,烟酰胺1.5%,樱花花提取物0.5%,山茶花提取物0.3%,香榧籽提取物0.4%,白睡莲提取物0.3%,鱼腥草提取物0.4%,红景天提取物3%,黑豆提取物2%,桑白皮提取物2%,苦参提取物2%,增稠剂0.14%,瞬间祛皱剂0.3%,水解透明质酸钠0.01%,透明质酸钠0.03%,保湿剂0.4%,螯合剂0.03%,酸碱调节剂0.14%,香精0.02%,水补充至100%。
增稠剂为卡波姆、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物、黄原胶、小核菌胶中的至少两种;保湿剂为酵母多糖,螯合剂为乙二胺四乙酸二钠,酸碱调节剂为氨丁三醇。
一种以光甘草定为主具有高效美白的精华液的制备方法,包括以下步骤:
步骤1:取适量水,加热至70℃后依次加入增稠剂、螯合剂、保湿剂、烟酰胺搅拌至完全溶解得到一次混合液;
步骤2:将一次混合液降温至57℃,依次加入樱花提取物、山茶花提取物、香榧籽提取物、白睡莲提取物、鱼腥草提取物、红景天提取物、黑豆提取物、桑白皮提取物、苦参提取物搅拌至完全溶解,得二次混合液;
步骤3:将二次混合液中依次加入瞬间祛皱剂、水解透明质酸钠、透明质酸钠搅拌至完全溶解,得三次混合液;
步骤4:将三次混合液降温37℃加入光甘草定搅拌至完全溶解,加入酸碱调节剂调节pH为6.0;
步骤5:加入香精,混合搅拌均匀后检测、包装、入库。
本发明的精华液含有多种植物提取物,制备工艺简单方便,易于控制,生产出的精华液很稳定,且易吸收、保湿、美白效果好,针对干性的皮肤容易长斑的人群特别的适用,包括一些皮肤暗沉没有光泽的皮肤。使用此款发明,可以有效阻碍黑色素的产生,不光起到日常护肤补品的作用,还可以防护肌肤,值得注意的是,精华液是最高浓度的保养品,用量得有一定标准。
以上所述的实施例仅仅是对本发明的优选实施方式进行描述,并非对本发明的范围进行限定,在不脱离本发明设计精神的前提下,本领域技术人员对本发明的技术方案做出的各种变形和改进,均应纳入本发明权利要求书确定的保护范围内。
Claims (5)
1.一种以光甘草定为主具有高效美白的精华液,其特征在于:由以下重量百分比的原料制成:光甘草定0-1%、烟酰胺0.5-5%、樱花提取物0-2%、山茶花提取物0-1.5%、香榧籽提取物0-2.5%、白睡莲提取物0-2%、鱼腥草提取物0-2%、红景天提取物0.5-6%、黑豆提取物0.5-5%、桑白皮提取物0.5-3%、苦参提取物0.1-5%、增稠剂0-0.9%、瞬间祛皱剂0.1-3%、水解透明质酸钠0.001-0.1%、透明质酸钠0.005-0.5%、保湿剂0.005-1%、螯合剂0.01-0.5%、酸碱调节剂0.01-4%、香精0.001-0.1%、水补足至100%。
2.根据权利要求1所述的一种以光甘草定为主具有高效美白的精华液,其特征在于:由以下重量百分比的原料制成:光甘草定0.02-0.5%、烟酰胺1-3%、樱花提取物0.01-0.5%、山茶花提取物0.05-0.3%、香榧籽提取物0.08-0.4%、白睡莲提取物0.08-0.3%、鱼腥草提取物0.01-0.4%、红景天提取物1-3%、黑豆提取物0.8-2%、桑白皮提取物0.6-2%、苦参提取物0.5-2%、增稠剂0.02-0.5%、瞬间祛皱剂0.1-1.5%、水解透明质酸0.005-0.1%、透明质酸钠0.005-0.1%、保湿剂0.1-0.5%、螯合剂0.01-0.05%、酸碱调节剂0.05-3%、香精0.001-0.05%、水补充至100%。
3.根据权利要求1或2所述的一种以光甘草定为主具有高效美白的精华液,其特征在于:所述增稠剂为卡波姆、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物、黄原胶、小核菌胶中的至少两种。
4.根据权利要求1或2所述的一种以光甘草定为主具有高效美白的精华液,其特征在于:所述保湿剂为酵母多糖,所述螯合剂为乙二胺四乙酸二钠,所述酸碱调节剂为氨丁三醇。
5.根据权利要求1或2所述的一种以光甘草定为主具有高效美白的精华液的制备方法,其特征在于,包括以下步骤:
步骤1:取适量水,加热至60-80℃后依次加入增稠剂、螯合剂、保湿剂、烟酰胺搅拌至完全溶解得到一次混合液;
步骤2:将一次混合液降温至55-60℃,依次加入樱花提取物、山茶花提取物、香榧籽提取物、白睡莲提取物、鱼腥草提取物、红景天提取物、黑豆提取物、桑白皮提取物、苦参提取物搅拌至完全溶解,得二次混合液;
步骤3:将二次混合液中依次加入瞬间祛皱剂、水解透明质酸钠、透明质酸钠搅拌至完全溶解,得三次混合液;
步骤4:将三次混合液降温35-40℃加入光甘草定搅拌至完全溶解,加入酸碱调节剂调节pH为5.0-7.0;
步骤5:加入香精,混合搅拌均匀后检测、包装、入库。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011505225.4A CN112451407A (zh) | 2020-12-18 | 2020-12-18 | 一种以光甘草定为主具有高效美白的精华液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011505225.4A CN112451407A (zh) | 2020-12-18 | 2020-12-18 | 一种以光甘草定为主具有高效美白的精华液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112451407A true CN112451407A (zh) | 2021-03-09 |
Family
ID=74803604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011505225.4A Pending CN112451407A (zh) | 2020-12-18 | 2020-12-18 | 一种以光甘草定为主具有高效美白的精华液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112451407A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114533618A (zh) * | 2022-03-21 | 2022-05-27 | 美出莱(杭州)化妆品有限责任公司 | 一种美白修复组合物及其制备方法和应用 |
CN115671024A (zh) * | 2022-12-07 | 2023-02-03 | 花安堂生物科技集团有限公司 | 樱花光甘草定复合发酵液、含其产品、及其制备和应用 |
CN114533618B (zh) * | 2022-03-21 | 2024-07-16 | 美出莱(杭州)化妆品有限责任公司 | 一种美白修复组合物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106727252A (zh) * | 2017-02-28 | 2017-05-31 | 广州诚予化妆品有限公司 | 一种具有美白效果的安全型精华液配方及其工艺 |
CN106852872A (zh) * | 2016-12-03 | 2017-06-16 | 长沙协浩吉生物工程有限公司 | 一种美白防晒霜的配制方法 |
CN110917051A (zh) * | 2019-11-07 | 2020-03-27 | 泉后(广州)生物科技研究院有限公司 | 一种美白精华液及其制备方法 |
-
2020
- 2020-12-18 CN CN202011505225.4A patent/CN112451407A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106852872A (zh) * | 2016-12-03 | 2017-06-16 | 长沙协浩吉生物工程有限公司 | 一种美白防晒霜的配制方法 |
CN106727252A (zh) * | 2017-02-28 | 2017-05-31 | 广州诚予化妆品有限公司 | 一种具有美白效果的安全型精华液配方及其工艺 |
CN110917051A (zh) * | 2019-11-07 | 2020-03-27 | 泉后(广州)生物科技研究院有限公司 | 一种美白精华液及其制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114533618A (zh) * | 2022-03-21 | 2022-05-27 | 美出莱(杭州)化妆品有限责任公司 | 一种美白修复组合物及其制备方法和应用 |
CN114533618B (zh) * | 2022-03-21 | 2024-07-16 | 美出莱(杭州)化妆品有限责任公司 | 一种美白修复组合物及其制备方法和应用 |
CN115671024A (zh) * | 2022-12-07 | 2023-02-03 | 花安堂生物科技集团有限公司 | 樱花光甘草定复合发酵液、含其产品、及其制备和应用 |
CN115671024B (zh) * | 2022-12-07 | 2023-03-28 | 花安堂生物科技集团有限公司 | 樱花光甘草定复合发酵液、含其产品、及其制备和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1635996B (zh) | 含有4-羟苯基-α-D-吡喃葡萄糖苷的皮肤用局部药剂 | |
CN108309829A (zh) | 含有山茶籽油的护肤乳及其制备方法 | |
CN109453087B (zh) | 美白透肌水及其制备方法和美白化妆品添加剂 | |
CN105769683A (zh) | 一种含有牡丹籽油的抗氧化保湿睡眠面膜及其制备方法 | |
CN106265264A (zh) | 一种祛痘组合物及其制备方法 | |
CN111184662A (zh) | 一种小分子肽肌底修护精华液 | |
CN109431908B (zh) | 美白保湿霜及其制备方法和美白化妆品添加剂 | |
CN109363998B (zh) | 美白化妆品添加剂和美白精华原液及其制备方法 | |
JP2011213660A (ja) | 抗酸化剤、紫外線傷害抑制剤及び抗光老化化粧料 | |
CN109806211A (zh) | 一种肌肤修护面膜及其制备方法 | |
CN112451407A (zh) | 一种以光甘草定为主具有高效美白的精华液及其制备方法 | |
CN111658591A (zh) | 一种美白淡斑霜化妆品及其制备方法 | |
CN113181097B (zh) | 一种祛痘淡斑植物复方纯露及其制备方法与应用 | |
CN112516054B (zh) | 一种修护保湿强化肌肤的茶多酚蛋白霜及其生产工艺 | |
CN110025553A (zh) | 一种透亮润泽面膜及其制备方法 | |
CN102058513B (zh) | 一种中草药原液及含该原液的化妆品 | |
CN113041209A (zh) | 美白面膜膏 | |
CN111166707B (zh) | 一种面部抗衰修复护理组合物及其制备方法和应用 | |
CN112266825A (zh) | 一种复配精油、其制备方法及其在美白抗皱化妆品中的应用 | |
CN110974775A (zh) | 一种含葛仙米的舒敏组合物及其制备方法和应用 | |
CN113384511A (zh) | 一种高功效精华化妆水的配方及其制备方法 | |
CN112438936A (zh) | 一种天然多效保湿润肤露及其制备方法 | |
CN112675123A (zh) | 三白活性组合物、制备方法及其应用 | |
CN113797144A (zh) | 一种含铁皮石斛提取物的炭黑面膜精华液及其制备方法 | |
CN106901995A (zh) | 一种酵素祛斑防晒霜的配制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210309 |
|
RJ01 | Rejection of invention patent application after publication |